<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The superacute stage of focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> can be visualized using T2-weighted MRI following the injection of superparamagnetic <z:chebi fb="27" ids="50820">iron oxide</z:chebi> particles (<z:chebi fb="8" ids="46726">magnetite</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>In this study we evaluated the optimal time point, i.e. the time producing the strongest signal, for the injection of <z:chebi fb="8" ids="46726">magnetite</z:chebi> using T2-weighted MRI following left parmanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (lt.-PMCAO) </plain></SENT>
<SENT sid="2" pm="."><plain>Male Sprague-Dawley rats were anesthetized and the left middle cerebral artery (lt.-<z:chebi fb="70" ids="34342">MCA</z:chebi>) was permanently occluded </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="8" ids="46726">Magnetite</z:chebi> was then injected into the femoral vein after 20 to 30 min of lt.-PMCAO </plain></SENT>
<SENT sid="4" pm="."><plain>T2-weighted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> images were taken immediately, and 15 and 30 min after <z:chebi fb="8" ids="46726">magnetite</z:chebi> injection </plain></SENT>
<SENT sid="5" pm="."><plain>A high signal area at the region of the lt.-<z:chebi fb="70" ids="34342">MCA</z:chebi> was clearly seen on the T2-weighted MRI immediately after <z:chebi fb="8" ids="46726">magnetite</z:chebi> injection </plain></SENT>
<SENT sid="6" pm="."><plain>However, it became less clear after 15 min, and by 30 min could not be distinguished </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest that <z:chebi fb="8" ids="46726">magnetite</z:chebi> should be injected immediately prior to T2-weighted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging during the superacute stage of focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>